Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $24,154 | 1,300 | 99.2% |
| Education | $153.99 | 2 | 0.6% |
| Long term medical supply or device loan | $18.08 | 1 | 0.1% |
| Travel and Lodging | $16.46 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $4,296 | 233 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $3,547 | 204 | $0 (2024) |
| Janssen Biotech, Inc. | $2,082 | 103 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,018 | 84 | $0 (2024) |
| Celgene Corporation | $1,825 | 107 | $0 (2024) |
| QOL Medical, LLC | $1,522 | 67 | $0 (2024) |
| PFIZER INC. | $1,185 | 56 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $942.43 | 68 | $0 (2023) |
| Merck Sharp & Dohme LLC | $860.62 | 48 | $0 (2024) |
| Allergan, Inc. | $816.56 | 44 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,045 | 187 | ABBVIE INC. ($730.73) |
| 2023 | $3,890 | 215 | ABBVIE INC. ($685.10) |
| 2022 | $4,018 | 209 | ABBVIE INC. ($849.21) |
| 2021 | $2,626 | 121 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($624.41) |
| 2020 | $1,199 | 65 | AbbVie Inc. ($275.21) |
| 2019 | $3,096 | 170 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($615.28) |
| 2018 | $2,965 | 187 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($567.37) |
| 2017 | $2,504 | 150 | Valeant Pharmaceuticals North America LLC ($385.98) |
All Payment Transactions
1,304 individual payment records from CMS Open Payments — Page 1 of 53
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Gastroenterology | ||||||
| 12/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.92 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $33.54 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $25.02 | General |
| Category: GI | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $30.82 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $31.19 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $17.51 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/26/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/26/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 917 | 970 | $844,325 | $126,225 |
| 2022 | 15 | 879 | 925 | $798,290 | $131,876 |
| 2021 | 15 | 828 | 888 | $507,925 | $111,972 |
| 2020 | 16 | 639 | 737 | $356,015 | $72,815 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 94 | 94 | $192,700 | $15,022 | 7.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 185 | $69,375 | $14,568 | 21.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 89 | 89 | $155,750 | $14,162 | 9.1% |
| 91120 | Test for tone and sensation of rectum and anus | Office | 2023 | 28 | 28 | $33,600 | $13,032 | 38.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 106 | $42,400 | $12,116 | 28.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 108 | 108 | $48,600 | $10,330 | 21.3% |
| 91122 | Study of rectum sensitivity and function | Office | 2023 | 28 | 28 | $28,000 | $7,137 | 25.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 133 | 133 | $46,550 | $6,617 | 14.2% |
| 91038 | Prolonged monitoring and recording of esophageal function through nasal tube with electrode | Office | 2023 | 16 | 17 | $17,000 | $6,513 | 38.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 58 | 58 | $104,400 | $5,917 | 5.7% |
| 91010 | Study of esophagus to assess movement | Office | 2023 | 29 | 29 | $29,000 | $5,906 | 20.4% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 21 | 21 | $44,100 | $4,882 | 11.1% |
| 91037 | Monitoring and recording of esophageal function through nasal tube with electrode | Office | 2023 | 29 | 29 | $14,500 | $4,545 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $15,000 | $4,294 | 28.6% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 15 | 15 | $3,350 | $1,185 | 35.4% |
| 91120 | Test for tone and sensation of rectum and anus | Office | 2022 | 35 | 35 | $41,500 | $18,142 | 43.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 137 | 158 | $58,250 | $17,434 | 29.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 99 | 100 | $199,000 | $16,706 | 8.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 133 | 153 | $52,205 | $11,557 | 22.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 115 | 115 | $48,750 | $10,525 | 21.6% |
| 91122 | Study of rectum sensitivity and function | Office | 2022 | 35 | 35 | $34,650 | $9,287 | 26.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 33 | 33 | $66,000 | $7,695 | 11.7% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 48 | 48 | $82,650 | $7,624 | 9.2% |
| 91010 | Study of esophagus to assess movement | Office | 2022 | 28 | 28 | $27,600 | $5,951 | 21.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 64 | 66 | $115,800 | $5,743 | 5.0% |
About Dr. Barry Jaffin, MD
Dr. Barry Jaffin, MD is a Gastroenterology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801815105.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barry Jaffin, MD has received a total of $24,342 in payments from pharmaceutical and medical device companies, with $4,045 received in 2024. These payments were reported across 1,304 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($24,154).
As a Medicare-enrolled provider, Jaffin has provided services to 3,263 Medicare beneficiaries, totaling 3,520 services with total Medicare billing of $442,887. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location New York, NY
- Active Since 07/18/2006
- Last Updated 05/27/2010
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801815105
Products in Payments
- XIFAXAN (Drug) $2,924
- ZEPOSIA (Drug) $1,972
- STELARA (Biological) $1,795
- ENTYVIO (Biological) $1,416
- Humira (Biological) $1,119
- LINZESS (Drug) $1,100
- XELJANZ (Drug) $1,027
- SUCRAID (Drug) $806.05
- DIFICID (Drug) $768.92
- HUMIRA (Biological) $742.92
- Cimzia (Drug) $741.87
- RINVOQ (Biological) $735.20
- Sucraid (Drug) $715.56
- Entyvio (Biological) $634.55
- SKYRIZI (Biological) $621.84
- CLENPIQ (Drug) $517.51
- CREON (Drug) $451.28
- TRULANCE (Drug) $430.11
- ZENPEP (Drug) $401.13
- DUPIXENT (Biological) $338.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New York
Arthur Kornbluth, Md, MD
Gastroenterology — Payments: $2.4M
Dr. David Carr-Locke, Md Frcp Facg Masge, MD FRCP FACG MASGE
Gastroenterology — Payments: $2.3M
Jean-Frederic Colombel, M.d, M.D
Gastroenterology — Payments: $1.1M
Dr. Bruce Sands, Md, MD
Gastroenterology — Payments: $1.0M
Ellen Scherl, Md, MD
Gastroenterology — Payments: $880,329
Sonal Kumar, Md, MD
Gastroenterology — Payments: $769,554